UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
   Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934

           Date of Report (Date of earliest reported): October 5, 2006

                         ADDISON-DAVIS DIAGNOSTICS, INC.
               (Exact name of registrant as specified in charter)

          Delaware                     000-25022                  800103134
(State or other jurisdiction          (Commission               (IRS Employer
      of incorporation)               File Number)           Identification No.)

               143 Triunfo Canyon Road Westlake Village, CA 91361
       Registrant's telephone number, including area code: (805) 494-7838

                                   Copies to:
                             Darrin M. Ocasio, Esq.
                       Sichenzia Ross Friedman Ference LLP
              1065 Avenue of the Americas New York, New York 10018
                              Phone: (212) 930-9700
                               Fax: (212) 930-9725

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act 17 CFR 240.13e-4(c))



Item 1.03  Bankruptcy or Receivership.

As previously  disclosed by Addison-Davis  Diagnostics,  Inc. (the "Company") in
its periodic filings with the Securities and Exchange Commission,  on January 5,
2005,  Steven H. Reder ("Reder"),  a former officer and director of the Company,
filed a  lawsuit  against  the  Company  in the  Superior  Court of the State of
California for the County of Los Angeles (the "Court") entitled Steven Reder vs.
QT5, Inc., a Delaware corporation, now known as Addison-Davis Diagnostics, Inc.,
a Delaware  corporation  Case No. BC 326875,  alleging  breach of his employment
agreement,  wrongful  discharge,  libel and breach of a certain  promissory note
(the "Action"). On September 15, 2006, the Court announced that it would rule in
favor of Mr. Reder and  tentatively  awarded damages in the amount of $1,926,950
to Mr. Reder by the Company.  No judgment has been entered by the Court and as a
result of the automatic stay imposed  pursuant to 11 U.S.C.  Section 362(a) as a
result of the filing of the Company  Bankruptcy  Petition (as defined  below) on
October 5, 2006,  any  further  action in the  Action is stayed,  including  the
submission of and the entry of a judgment.

On October 5, 2006, the Company, filed a voluntary bankruptcy case under Chapter
11 of the United States Bankruptcy Code (the "Company Bankruptcy Petition"). The
Company Bankruptcy  Petition was filed in the United States Bankruptcy Court for
the  Central  District of  California,  San  Fernando  Valley  Division,  and is
designated as case number SV 06-11790 MT. The date  jurisdiction  was assumed is
October 5, 2006. As this is a Chapter 11 case,  the Company has been and remains
the Debtor in  Possession  and as such has the rights and duties of a trustee as
of the date of the October 5, 2006 case commencement.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

      (a)   Financial statements of business acquired.

            Not applicable.

      (b)   Pro forma financial information.

            Not applicable.

      (c)   Exhibits.

            None.



                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                ADDISON-DAVIS DIAGNOSTICS, INC.

Date: October 19, 2006          /s/ Charles Miseroy
                                --------------------
                                    Charles Miseroy
                                    Chief Executive Officer